Campaigns to reduce antibiotic use in the US cannot compete with drug advertising, study saysBMJ 2009; 339 doi: https://doi.org/10.1136/bmj.b3785 (Published 15 September 2009) Cite this as: BMJ 2009;339:b3785
- Bob Roehr
- 1Washington, DC
Regional public education campaigns in the United States to promote more appropriate use of antibiotics among outpatients are underfunded and seldom evaluated for effectiveness, concludes a study presented at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy in San Francisco on 12-15 September.
“The main problems in the US are that the programmes are not adequately funded or evaluated,” said the study’s lead author, Benedikt Huttner, from Geneva, Switzerland. Many operate on $100 000 (£60 000; $70 000) a year or less, which pays for little more than the salary of a programme administrator. “There is very little money left over for the interventions themselves,” …